LUCD · Lucid Diagnostics Inc. · Earnings Call Transcripts & Audio
$0.75
-0.06 (-7.17%)
At close · Sep 30
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern within one year after the date the accompanying unaudited condensed consolidated financial statements are issued.”View the 10-Q filed Aug 12, 2026
Market Cap
$167.88M
Shares
203.24M
Volume · Sep 30
1.78M
Avg daily vol (3M)
1.22M
Lucid Diagnostics Inc. Earnings Call Transcripts
Quarterly earnings calls for Lucid Diagnostics Inc. (LUCD), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▼62%
$76,000
−$14.35M
'22 Q3
22-11-14
▲136%
$446,000
−$16.25M
'23 Q1
23-03-31
·
$159,000
−$11.38M
'23 Q2
23-06-30
▲930.3%
$783,000
−$14.21M
'23 Q3
23-11-14
▲124.4%
$1.00M
−$10.61M
'24 Q1
24-05-14
▲513.8%
$976,000
−$11.01M
'24 Q2
24-08-12
▲49.7%
$1.17M
−$12.37M
'24 Q3
24-11-13
▲15.1%
$1.20M
−$11.54M
'24 Q4
25-03-25
▼17.3%
$828,000
−$26.91M
'25 Q1
25-05-14
▲19.2%
$1.16M
−$4.44M
'25 Q2
25-08-13
▲3.3%
$1.21M
−$10.40M
'25 Q3
25-11-12
▲25.6%
$1.50M
−$16.27M
'25 Q4
26-03-26
▲51.7%
$1.26M
−$13.91M
'26 Q1
26-05-14
LATEST
▲26.7%
$1.47M
−$11.69M
'26 Q2
26-08-13
Earnings call
FY26 · Q2
2026-08-13
Lucid Diagnostics Inc. (LUCD) Q2 2026 Earnings Call Transcript
Positive tone
Test volume and revenue
CONCERT LBM coverage
Medicare LCD
Revenue
$1.47M
▲ 26.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-08-11
Lucid Diagnostics Inc. (LUCD) August 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-14
Lucid Diagnostics Inc. (LUCD) Q1 2026 Earnings Call Transcript
Positive tone
Test volume and sales productivity
Operating expenses and cash burn
Balance sheet and financing
Revenue
$1.26M
▲ 51.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-04-16
Lucid Diagnostics Inc. (LUCD) April 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-03-26
Lucid Diagnostics Inc. (LUCD) Q4 2025 Earnings Call Transcript
Positive tone
Medicare reimbursement and MolDx LCD
EsoGuard test volume and revenue
Commercial payer coverage
Revenue
$1.50M*
▲ 25.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-12
Lucid Diagnostics Inc. (LUCD) Q3 2025 Earnings Call Transcript
Confident tone
Medicare / MolDx CAC Meeting
EsoGuard Commercial Volume and Revenue
Market Access and Commercial Payer Coverage
Revenue
$1.21M
▲ 3.3% YoY Diluted EPS
$-0.10
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-13
Lucid Diagnostics Inc. (LUCD) Q2 2025 Earnings Call Transcript
Positive tone
Medicare LCD / CAC meeting
EsoGuard test volume and revenue
Hoag health system partnership
Revenue
$1.16M
▲ 19.2% YoY Diluted EPS
$-0.08
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-14
Lucid Diagnostics Inc. (LUCD) Q1 2025 Earnings Call Transcript
Confident tone
Cash-pay concierge medicine channel
Medicare/MolDX reimbursement
Employer and fire department testing
Revenue
$828,000
▼ 17.3% YoY Diluted EPS
$-0.52
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-25
Lucid Diagnostics Inc. (LUCD) Q4 2024 Earnings Call
Revenue
$1.20M*
▲ 15.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-13
Lucid Diagnostics Inc. (LUCD) Q3 2024 Earnings Call Transcript
Confident tone
Commercial volume and revenue
Medicare/CMS coverage submission
Clinical evidence and validation
Revenue
$1.17M
▲ 49.7% YoY Diluted EPS
$-0.25
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-12
Lucid Diagnostics Inc. (LUCD) Q2 2024 Earnings Call Transcript
Positive tone
Clinical data and validation studies
Direct contracting and guaranteed revenue
Check Your Food Tube (CYFT) health fair events
Revenue
$976,000
▲ 513.8% YoY Diluted EPS
$-0.23
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-14
Lucid Diagnostics Inc. (LUCD) Q1 2024 Earnings Call Transcript
Confident tone
EsoGuard Clinical Performance
Revenue and Test Volume
MolDX Medicare Coverage
Revenue
$1.00M
▲ 124.4% YoY Diluted EPS
$-0.40
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q3
2023-11-14
Lucid Diagnostics Inc. (LUCD) Q3 2023 Earnings Call Transcript
Revenue
$783,000
▲ 930.3% YoY Diluted EPS
$-0.34
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Lucid Diagnostics Inc. (LUCD) Q2 2023 Earnings Call Transcript
Revenue
$159,000
Diluted EPS
$-0.27
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Lucid Diagnostics Inc. (LUCD) Q1 2023 Earnings Call Transcript
Revenue
$446,000
▲ 136% YoY Diluted EPS
$-0.40
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-14
Lucid Diagnostics Inc. (LUCD) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-14
Lucid Diagnostics Inc. (LUCD) Q3 2022 Earnings Call Transcript
Revenue
$76,000
▼ 62% YoY Diluted EPS
$-0.39
Gross margin
100.0%
Rev · 3q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-15
Lucid Diagnostics Inc. (LUCD) Q2 2022 Earnings Call Transcript
Diluted EPS
$-0.41
Rev · 2q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-12
Lucid Diagnostics Inc. (LUCD) Q1 2022 Earnings Call Transcript
Revenue
$189,000
Gross margin
-95.2%
Rev · 2q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-28
Lucid Diagnostics Inc. (LUCD) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Showing 1–20 of 20 earnings calls